ATE56213T1 - Substituierte carbonsaeureamide, ihre herstellung und diese enthaltende pharmazeutische zubereitungen. - Google Patents

Substituierte carbonsaeureamide, ihre herstellung und diese enthaltende pharmazeutische zubereitungen.

Info

Publication number
ATE56213T1
ATE56213T1 AT87400078T AT87400078T ATE56213T1 AT E56213 T1 ATE56213 T1 AT E56213T1 AT 87400078 T AT87400078 T AT 87400078T AT 87400078 T AT87400078 T AT 87400078T AT E56213 T1 ATE56213 T1 AT E56213T1
Authority
AT
Austria
Prior art keywords
substituted
phenyl
alkyl
het
alkyloxy
Prior art date
Application number
AT87400078T
Other languages
English (en)
Inventor
Claude Cotrel
Claude Guyon
Gerard Roussel
Gerard Taurand
Original Assignee
Rhone Poulenc Sante
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Sante filed Critical Rhone Poulenc Sante
Application granted granted Critical
Publication of ATE56213T1 publication Critical patent/ATE56213T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Neurology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cephalosporin Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Protection Of Plants (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Reinforced Plastic Materials (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT87400078T 1986-01-16 1987-01-15 Substituierte carbonsaeureamide, ihre herstellung und diese enthaltende pharmazeutische zubereitungen. ATE56213T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8600556A FR2592882B2 (fr) 1986-01-16 1986-01-16 Nouveaux amides substitues, leur preparation et les medicaments qui les contiennent
EP87400078A EP0234971B1 (de) 1986-01-16 1987-01-15 Substituierte Carbonsäureamide, ihre Herstellung und diese enthaltende pharmazeutische Zubereitungen

Publications (1)

Publication Number Publication Date
ATE56213T1 true ATE56213T1 (de) 1990-09-15

Family

ID=9331170

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87400078T ATE56213T1 (de) 1986-01-16 1987-01-15 Substituierte carbonsaeureamide, ihre herstellung und diese enthaltende pharmazeutische zubereitungen.

Country Status (21)

Country Link
US (1) US4753933A (de)
EP (1) EP0234971B1 (de)
JP (1) JPS62169787A (de)
KR (1) KR870007169A (de)
AT (1) ATE56213T1 (de)
AU (1) AU589484B2 (de)
CS (1) CS262446B2 (de)
DD (1) DD260069A5 (de)
DE (1) DE3764667D1 (de)
DK (1) DK19787A (de)
ES (1) ES2018025B3 (de)
FI (1) FI870150A7 (de)
FR (1) FR2592882B2 (de)
HU (1) HU196070B (de)
IE (1) IE870126L (de)
NO (1) NO164836C (de)
PH (1) PH24461A (de)
PL (1) PL263677A3 (de)
PT (1) PT84101B (de)
YU (1) YU46041B (de)
ZA (1) ZA87292B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5258356A (en) * 1989-03-11 1993-11-02 Basf Aktiengesellschaft Substituted 1,8-naphthyridines, their preparation and their use as antidotes
EP1195372A1 (de) * 1994-04-18 2002-04-10 Mitsubishi Pharma Corporation N-Heterozyklisch substitutierte Benzamid Deriviate mit antihypertensiver Wirkung
WO1997024401A1 (en) * 1995-12-27 1997-07-10 Sumitomo Bakelite Company Limited Process for producing flame-retardant, silane-crosslinked polyolefin
GB9711257D0 (en) 1997-05-30 1997-07-30 Smithkline Beecham Plc Novel compounds
US6340690B1 (en) 1999-02-22 2002-01-22 Bio-Chem Pharma Inc. Antiviral methods using [1,8]naphthyridine derivatives

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1006725A (fr) * 1948-08-31 1952-04-28 Cilag Spa Nouveaux dérivés de la naphtyridine et procédé pour leur préparation
FR2567887B1 (fr) * 1984-07-19 1986-12-19 Rhone Poulenc Sante Nouveaux amides substitues, leur preparation et les medicaments qui les contiennent
EP0208621B1 (de) * 1985-07-11 1989-04-12 Rhone-Poulenc Sante Substituierte Amide, ihre Herstellung und diese enthaltende Zubereitungen

Also Published As

Publication number Publication date
FR2592882A2 (fr) 1987-07-17
FI870150A7 (fi) 1987-07-17
CS262446B2 (en) 1989-03-14
EP0234971B1 (de) 1990-09-05
KR870007169A (ko) 1987-08-17
NO870166D0 (no) 1987-01-15
NO870166L (no) 1987-07-17
DD260069A5 (de) 1988-09-14
EP0234971A1 (de) 1987-09-02
AU6760287A (en) 1987-07-23
NO164836B (no) 1990-08-13
ES2018025B3 (es) 1991-03-16
PT84101A (fr) 1987-02-01
AU589484B2 (en) 1989-10-12
PT84101B (pt) 1989-07-31
YU5387A (en) 1988-06-30
JPS62169787A (ja) 1987-07-25
PH24461A (en) 1990-06-25
FI870150A0 (fi) 1987-01-15
FR2592882B2 (fr) 1988-03-11
PL263677A3 (en) 1988-06-09
CS25687A2 (en) 1988-07-15
US4753933A (en) 1988-06-28
HUT43603A (en) 1987-11-30
DK19787D0 (da) 1987-01-15
ZA87292B (en) 1987-08-26
YU46041B (sh) 1992-12-21
HU196070B (en) 1988-09-28
DK19787A (da) 1987-07-17
DE3764667D1 (de) 1990-10-11
IE870126L (en) 1987-07-16
NO164836C (no) 1990-11-21

Similar Documents

Publication Publication Date Title
DK586588D0 (da) Terapeutiske heterocycliske forbindelser
EP0638560A4 (de) Heilmittel für osteoporose und diazepinverbindung*.
DE58909248D1 (de) Heterocyclisch substituierte alfa-Aryl-acrylsäureester und Fungizide, die diese Verbindungen enthalten.
ATE174917T1 (de) Pyrazolo(1,5-a>pyrimidinderivate und sie enthaltende antiinflammatorische mittel
MY101208A (en) Phenyl-piperazine anti-arrhythmia agents.
EG18273A (en) N-phosphonylmethoxyalkyl pyrimidines and purines and therapeutic application thereof
ATE211384T1 (de) Verwendung von adenosinantagonisten zur vorbeugung und behandlung von pankreatitis und ulcera
DE69818286D1 (de) Pyridylverbindungen und diese enthaltende pharmazeutische zubereitungen
DE69006907D1 (de) Arylthiazolylimidazole als 5HT3-Antagonisten.
DE68923151D1 (de) Verwendung von Trifluormethylphenyl-Tetrahydropyridinen zur Herstellung von Arzneimitteln zur Behandlung anxio-depressiver Erkrankungen.
ATE56213T1 (de) Substituierte carbonsaeureamide, ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
FR2594332B1 (fr) Derives d'acides amino-benzoiques, d'acides hydroxy-benzoiques, d'acides cinnamiques, d'acide urocanique et de benzimidazole presentant ou non un groupement d'acide amine absorbant les uvb et/ou les uva et permettant d'eviter les photodermatoses, chez l'homme, consecutives a l'administration de medicaments, a l'emploi de cosmetiques parfumes ou de parfums
DE69837334D1 (de) Heterozyclische verbindungen, ihr herstellungsverfahren und diese enthaltende pharmazeutische zusammensetzungen
IT1216104B (it) Peptidi ad attivita' farmaceutica.
DE3778642D1 (de) Therapeutikum zur behandlung von magengeschwueren.
IE890293L (en) Quinolone derivatives
DE69827706D1 (de) 5-(Heteroaryl)alkyl)-3-oxo-pyrido(1,2-a)benzimidazol-4-carboxamid (PBI) Derivate zur Behandlung von Störungen des zentralen Nervensystems
IT1216103B (it) Peptidi ad attivita' farmaceutica.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties